Breathomics: May it Become an Affordable, New Tool for Early Diagnosis and Screening of Lung Cancer?

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

September 1, 2022

Study Completion Date

August 1, 2023

Conditions
Lung Cancer
Interventions
DEVICE

Portable GC device for brath analysis

Patients were asked to orally exhale 1-2 L breath into a 5 L Tedlar bag via a one-way mouthpiece and Nafion filter for moisture removal, as shown in Figure 1B. The process usually takes about a few minutes. The breath analysis took place either in-situ immediately after the breath sample collection or within 24 h of breath collection. The Tedlar bags were stored under ambient condition until analyzed. During the breath analysis, the Tedlar bag was connected to the sampling port of the portable GC (Figure 1C). Approximately 350 mL of breath was pulled from the Tedlar bag into the GC for analysis. The GC operation was controlled using LabView via a laptop. The total assay time was 30 min, including 5 min of breath sampling time from the Tedlar bag at a flow rate of 70 mL/min (see the blue path in Figure 1A), 5 min of desorption/transfer time, 10 min of chromatographic separation time (see the orange path in Figure 1A), and 10 min of GC system cleaning time.

Trial Locations (1)

70121

Azienda Consorziale Ospedaliero-Universitaria Policlinico di Bari - Thoracic Surgery Unit, Bari

All Listed Sponsors
collaborator

University of Michigan

OTHER

collaborator

Humanitas Hospital, Italy

OTHER

lead

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

OTHER

NCT06034730 - Breathomics: May it Become an Affordable, New Tool for Early Diagnosis and Screening of Lung Cancer? | Biotech Hunter | Biotech Hunter